APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmol Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmol Drug Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchOphthalmol Drug Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmol Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Ophthalmol Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmol Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmol Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ophthalmol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmol Drug include Akorn, Allergan, Regeneron, Senju, Valeant, Bayer, Santen, Pfizer and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmol Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmol Drug market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmol Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmol Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmol Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmol Drug Market by Company

Akorn

Allergan

Regeneron

Senju

Valeant

Bayer

Santen

Pfizer

Roche

Novartis

Ophthalmol Drug Segment by Type

Retinal disorders drugs

Glaucoma drugs

Allergic, inflammatory and infective drugs

Dry eye drugs

Ophthalmol Drug Segment by Application

Retinal diseases

Glaucoma

Dry eye syndrome

Other ophthalmic indications

Ophthalmol Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmol Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmol Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Retinal disorders drugs Table 2. Major Company of Glaucoma drugs Table 3. Major Company of Allergic, inflammatory and infective drugs Table 4. Major Company of Dry eye drugs Table 5. Global Ophthalmol Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 7. Global Ophthalmol Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Ophthalmol Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Ophthalmol Drug Price by Type (2021-2026) & (US$/Ton) Table 11. Global Ophthalmol Drug Sales by Type (2027-2032) & (W Tons) Table 12. Global Ophthalmol Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Ophthalmol Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Ophthalmol Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Ophthalmol Drug Price by Type (2027-2032) & (US$/Ton) Table 16. North America Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 17. North America Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 19. Europe Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 21. Asia-Pacific Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 23. Latin America Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Ophthalmol Drug Sales by Type (2021-2026) & (W Tons) Table 25. Middle East and Africa Ophthalmol Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Ophthalmol Drug Industry Trends Table 27. Ophthalmol Drug Industry Drivers Table 28. Ophthalmol Drug Industry Opportunities and Challenges Table 29. Ophthalmol Drug Industry Restraints Table 30. Global Ophthalmol Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Ophthalmol Drug Revenue Market Share by Company (2021-2026) Table 32. Global Ophthalmol Drug Sales by Company (2021-2026) & (W Tons) Table 33. Global Ophthalmol Drug Sales Share by Company (2021-2026) Table 34. Global Ophthalmol Drug Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Ophthalmol Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Ophthalmol Drug Major Company Production Sites and Headquarters Table 37. Global Ophthalmol Drug Company, Product Type & Application Table 38. Global Ophthalmol Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Ophthalmol Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Ophthalmol Drug Sales by Region (2021-2026) & (W Tons) Table 43. Global Ophthalmol Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Ophthalmol Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Ophthalmol Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Ophthalmol Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Ophthalmol Drug Sales by Region (2027-2032) & (W Tons) Table 48. Global Ophthalmol Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Ophthalmol Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Ophthalmol Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Ophthalmol Drug Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Ophthalmol Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 54. Global Ophthalmol Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Ophthalmol Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Ophthalmol Drug Price by Application (2021-2026) & (US$/Ton) Table 58. Global Ophthalmol Drug Sales by Application (2027-2032) & (W Tons) Table 59. Global Ophthalmol Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Ophthalmol Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Ophthalmol Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Ophthalmol Drug Price by Application (2027-2032) & (US$/Ton) Table 63. North America Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 64. North America Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 66. Europe Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 68. Asia-Pacific Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 70. Latin America Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Ophthalmol Drug Sales by Application (2021-2026) & (W Tons) Table 72. Middle East and Africa Ophthalmol Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Akorn Company Information Table 74. Akorn Business Overview Table 75. Akorn Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Akorn Ophthalmol Drug Product Portfolio Table 77. Akorn Recent Development Table 78. Allergan Company Information Table 79. Allergan Business Overview Table 80. Allergan Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Allergan Ophthalmol Drug Product Portfolio Table 82. Allergan Recent Development Table 83. Regeneron Company Information Table 84. Regeneron Business Overview Table 85. Regeneron Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Regeneron Ophthalmol Drug Product Portfolio Table 87. Regeneron Recent Development Table 88. Senju Company Information Table 89. Senju Business Overview Table 90. Senju Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Senju Ophthalmol Drug Product Portfolio Table 92. Senju Recent Development Table 93. Valeant Company Information Table 94. Valeant Business Overview Table 95. Valeant Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Valeant Ophthalmol Drug Product Portfolio Table 97. Valeant Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Bayer Ophthalmol Drug Product Portfolio Table 102. Bayer Recent Development Table 103. Santen Company Information Table 104. Santen Business Overview Table 105. Santen Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Santen Ophthalmol Drug Product Portfolio Table 107. Santen Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Pfizer Ophthalmol Drug Product Portfolio Table 112. Pfizer Recent Development Table 113. Roche Company Information Table 114. Roche Business Overview Table 115. Roche Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Roche Ophthalmol Drug Product Portfolio Table 117. Roche Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Ophthalmol Drug Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Novartis Ophthalmol Drug Product Portfolio Table 122. Novartis Recent Development Table 123. North America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 124. North America Ophthalmol Drug Sales by Country (2021-2026) & (W Tons) Table 125. North America Ophthalmol Drug Sales Market Share by Country (2021-2026) Table 126. North America Ophthalmol Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 127. North America Ophthalmol Drug Sales Market Share Forecast by Country (2027-2032) Table 128. North America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Ophthalmol Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Ophthalmol Drug Market Share by Country (2021-2026) Table 131. North America Ophthalmol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Ophthalmol Drug Market Share Forecast by Country (2027-2032) Table 133. Europe Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 134. Europe Ophthalmol Drug Sales by Country (2021-2026) & (W Tons) Table 135. Europe Ophthalmol Drug Sales Market Share by Country (2021-2026) Table 136. Europe Ophthalmol Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 137. Europe Ophthalmol Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Ophthalmol Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Ophthalmol Drug Market Share by Country (2021-2026) Table 141. Europe Ophthalmol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Ophthalmol Drug Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Ophthalmol Drug Sales by Country (2021-2026) & (W Tons) Table 145. Asia-Pacific Ophthalmol Drug Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Ophthalmol Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 147. Asia-Pacific Ophthalmol Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Ophthalmol Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Ophthalmol Drug Market Share by Country (2021-2026) Table 151. Asia-Pacific Ophthalmol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Ophthalmol Drug Market Share Forecast by Country (2027-2032) Table 153. Latin America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 154. Latin America Ophthalmol Drug Sales by Country (2021-2026) & (W Tons) Table 155. Latin America Ophthalmol Drug Sales Market Share by Country (2021-2026) Table 156. Latin America Ophthalmol Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 157. Latin America Ophthalmol Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Ophthalmol Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Ophthalmol Drug Market Share by Country (2021-2026) Table 161. Latin America Ophthalmol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Ophthalmol Drug Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Ophthalmol Drug Sales by Country (2021-2026) & (W Tons) Table 165. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Ophthalmol Drug Sales Forecast by Country (2027-2032) & (W Tons) Table 167. Middle East and Africa Ophthalmol Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Ophthalmol Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Ophthalmol Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Ophthalmol Drug Market Share by Country (2021-2026) Table 171. Middle East and Africa Ophthalmol Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Ophthalmol Drug Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Ophthalmol Drug Distributors List Table 176. Ophthalmol Drug Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Ophthalmol Drug Image Figure 2. Global Ophthalmol Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmol Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmol Drug Sales (2021-2032) & (W Tons) Figure 5. Retinal disorders drugs Image Figure 6. Global Retinal disorders drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Glaucoma drugs Image Figure 8. Global Glaucoma drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Allergic, inflammatory and infective drugs Image Figure 10. Global Allergic, inflammatory and infective drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Dry eye drugs Image Figure 12. Global Dry eye drugs Sales YoY Growth (2021-2032) & (W Tons) Figure 13. Global Ophthalmol Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Ophthalmol Drug Market Share by Type 2025 VS 2032 Figure 15. North America Ophthalmol Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Ophthalmol Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Ophthalmol Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Ophthalmol Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Ophthalmol Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Ophthalmol Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Ophthalmol Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Ophthalmol Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Ophthalmol Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Ophthalmol Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Ophthalmol Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Retinal diseases Image Figure 28. Global Retinal diseases Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Glaucoma Image Figure 30. Global Glaucoma Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Dry eye syndrome Image Figure 32. Global Dry eye syndrome Sales YoY Growth (2021-2032) & (W Tons) Figure 33. Other ophthalmic indications Image Figure 34. Global Other ophthalmic indications Sales YoY Growth (2021-2032) & (W Tons) Figure 35. Global Ophthalmol Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Ophthalmol Drug Market Share by Application 2025 VS 2032 Figure 37. North America Ophthalmol Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Ophthalmol Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Ophthalmol Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Ophthalmol Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Ophthalmol Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Ophthalmol Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Ophthalmol Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Ophthalmol Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Ophthalmol Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Ophthalmol Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Ophthalmol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. North America Ophthalmol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Ophthalmol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Ophthalmol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ophthalmol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Europe Ophthalmol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Ophthalmol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Ophthalmol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ophthalmol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Asia-Pacific Ophthalmol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Ophthalmol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Ophthalmol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ophthalmol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Latin America Ophthalmol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Ophthalmol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Ophthalmol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ophthalmol Drug Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 64. Middle East and Africa Ophthalmol Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Ophthalmol Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Ophthalmol Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Ophthalmol Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Ophthalmol Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Retinal disorders drugs
  • Glaucoma drugs
  • Allergic, inflammatory and infective drugs
  • Dry eye drugs
Applications
  • Retinal diseases
  • Glaucoma
  • Dry eye syndrome
  • Other ophthalmic indications
Companies covered
  • Akorn
  • Allergan
  • Regeneron
  • Senju
  • Valeant
  • Bayer
  • Santen
  • Pfizer
  • Roche
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmol Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmol Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmol Drug Market by Type
  6. 1.3.1 Retinal disorders drugs
  7. 1.3.2 Glaucoma drugs
  8. 1.3.3 Allergic, inflammatory and infective drugs
  9. 1.3.4 Dry eye drugs
  10. 1.4 Global Ophthalmol Drug Market Size by Type
  11. 1.4.1 Global Ophthalmol Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Ophthalmol Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Ophthalmol Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Ophthalmol Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Ophthalmol Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Ophthalmol Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Ophthalmol Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Ophthalmol Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmol Drug Industry Trends
  2. 2.2 Ophthalmol Drug Industry Drivers
  3. 2.3 Ophthalmol Drug Industry Opportunities and Challenges
  4. 2.4 Ophthalmol Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmol Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmol Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmol Drug Price (2021-2026)
  4. 3.4 Global Ophthalmol Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmol Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmol Drug Company, Product Type & Application
  7. 3.7 Global Ophthalmol Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmol Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmol Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmol Drug Tier 1, Tier 2, and Tier 3
4 Ophthalmol Drug Regional Status and Outlook
  1. 4.1 Global Ophthalmol Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmol Drug Historic Market Size by Region
  3. 4.2.1 Global Ophthalmol Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmol Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmol Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmol Drug Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmol Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmol Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmol Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmol Drug by Application
  1. 5.1 Ophthalmol Drug Market by Application
  2. 5.1.1 Retinal diseases
  3. 5.1.2 Glaucoma
  4. 5.1.3 Dry eye syndrome
  5. 5.1.4 Other ophthalmic indications
  6. 5.2 Global Ophthalmol Drug Market Size by Application
  7. 5.2.1 Global Ophthalmol Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Ophthalmol Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Ophthalmol Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Ophthalmol Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Ophthalmol Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Ophthalmol Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Ophthalmol Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Ophthalmol Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Akorn
  2. 6.1.1 Akorn Company Information
  3. 6.1.2 Akorn Business Overview
  4. 6.1.3 Akorn Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Akorn Ophthalmol Drug Product Portfolio
  6. 6.1.5 Akorn Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Ophthalmol Drug Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Regeneron
  14. 6.3.1 Regeneron Company Information
  15. 6.3.2 Regeneron Business Overview
  16. 6.3.3 Regeneron Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Regeneron Ophthalmol Drug Product Portfolio
  18. 6.3.5 Regeneron Recent Developments
  19. 6.4 Senju
  20. 6.4.1 Senju Company Information
  21. 6.4.2 Senju Business Overview
  22. 6.4.3 Senju Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Senju Ophthalmol Drug Product Portfolio
  24. 6.4.5 Senju Recent Developments
  25. 6.5 Valeant
  26. 6.5.1 Valeant Company Information
  27. 6.5.2 Valeant Business Overview
  28. 6.5.3 Valeant Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Valeant Ophthalmol Drug Product Portfolio
  30. 6.5.5 Valeant Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Ophthalmol Drug Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Santen
  38. 6.7.1 Santen Company Information
  39. 6.7.2 Santen Business Overview
  40. 6.7.3 Santen Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Santen Ophthalmol Drug Product Portfolio
  42. 6.7.5 Santen Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Ophthalmol Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Roche
  50. 6.9.1 Roche Company Information
  51. 6.9.2 Roche Business Overview
  52. 6.9.3 Roche Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Roche Ophthalmol Drug Product Portfolio
  54. 6.9.5 Roche Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Ophthalmol Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Ophthalmol Drug Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmol Drug Sales by Country
  2. 7.1.1 North America Ophthalmol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmol Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmol Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmol Drug Market Size by Country
  6. 7.2.1 North America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmol Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmol Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmol Drug Sales by Country
  2. 8.1.1 Europe Ophthalmol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmol Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmol Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmol Drug Market Size by Country
  6. 8.2.1 Europe Ophthalmol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmol Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmol Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmol Drug Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmol Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmol Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmol Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmol Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmol Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmol Drug Sales by Country
  2. 10.1.1 South America Ophthalmol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmol Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmol Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmol Drug Market Size by Country
  6. 10.2.1 South America Ophthalmol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmol Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmol Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmol Drug Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmol Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmol Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmol Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmol Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmol Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmol Drug Value Chain Analysis
  2. 12.1.1 Ophthalmol Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmol Drug Production Mode & Process
  7. 12.2 Ophthalmol Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmol Drug Distributors
  10. 12.2.3 Ophthalmol Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst